insights_auto
Why is VBIO down 3.17%?
Dive Deeperchevron_right
VBIO:NASDAQ
Valion Bio Inc
$2.14
arrow_downward
-3.17%(-0.070) 1D
$2.07
arrow_downward
-3.27% (-0.070)bedtimeAfter hours
Closed: Oct 9, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VBIO...
Open
$2.19
High
$2.27
Low
$2.10
Mkt. cap
1.90M
Avg. vol.
3.08M
Volume
140.57K
52-wk high
$32.50
52-wk low
$2.05
EPS
-$8.02
Beta
1.80
Shares outstanding
888.00K
No. of employees
52
Open
$2.19
High
$2.27
Low
$2.10
Mkt. cap
1.90M
Avg. vol.
3.08M
Volume
140.57K
52-wk high
$32.50
52-wk low
$2.05
EPS
-$8.02
Beta
1.80
Shares outstanding
888.00K
No. of employees
52
News stories
From web sources and news partners
Yahoo Finance
·
20 hours ago
Valion Bio (Nasdaq:VBIO): Oral Mucosal Entolimod Could Offer a New Needle-Free Deployment Path to Support Growing Need for Scalable Civilian Radiation Preparedness Should Nuclear Infrastructure Expand to Support Data Centers
Stock Titan
·
20 hours ago
A potential radiation drug could be absorbed through the mouth instead of injected.
About Valion Bio Inc
CEO-
Employees52
Founded2016
HeadquartersSan Antonio, Texas, United States
SectorBiotechnology
Websitevalionbio.com